Evaluating a telehealth provider comes down to seven questions: who reviews your intake, which pharmacy fulfils your prescription, is the consultation video or asynchronous, what happens if you're deemed ineligible, how are costs structured, who owns your medical records, and how the provider adjusts your protocol over time. Providers that answer all seven clearly are operating with clinical rigour. Providers that avoid any of them are worth walking away from.
The rise of cash-pay telehealth
Telehealth has moved from pandemic workaround to permanent infrastructure. Nearly one in five US adults reported using a telehealth platform in the last year, and the fastest-growing segment is cash-pay: patients paying out of pocket for care they can't get through their insurance-gated primary provider.
The reasons are practical. Traditional primary care is oriented around reactive medicine — disease management, symptom response, insurance-approved protocols. Cash-pay telehealth serves a different question: how do I optimise how I feel, function, and age, under the supervision of a licensed clinician who has the time to actually listen? For self-directed patients who have already done the reading, the friction of a fifteen-minute GP appointment is the reason they've gone elsewhere.
The catch is that "telehealth" as a term now covers everything from single-question urgent-care apps to full clinical programmes with ongoing supervision. The gap in quality between the best and the worst is wide, and most of it isn't visible on the landing page. The seven questions below are how you tell them apart.
Question 1: Who is reviewing my intake — a clinician or an algorithm?
Every telehealth provider needs a licensed clinician somewhere in the process to lawfully prescribe. What varies enormously is what that clinician actually does.
At one end, a state-licensed clinician reviews your full intake, medical history, symptoms, and goals, then makes a decision based on what you've written. At the other end, an automated system generates a recommendation from your form responses, a clinician rubber-stamps it in under sixty seconds, and the prescription is issued. Both are legal. The clinical rigour is not the same.
Ask the provider directly: how long does your clinician spend on my intake? If they can't give you an answer, you have your answer.
Question 2: Which pharmacy fills my prescription, and can they name it?
Every legitimate telehealth prescription is fulfilled by a licensed pharmacy. In the US, that will typically be either a retail pharmacy (for FDA-approved finished drug products) or a 503A compounding pharmacy — a state-licensed facility that prepares patient-specific formulations under a valid prescription.
Providers who name their pharmacy partner publicly are signalling something. They're saying: we've done the due diligence on sourcing, and we're willing to be accountable for it. Providers who won't name their pharmacy are asking you to trust them on the most consequential part of the entire process.
The right answer to "which pharmacy fills my prescription?" is a specific name, a location, and — if you push — the pharmacy's licence identifier. If the provider dodges, that's the signal.
Question 3: Is the consultation video or asynchronous, and does it matter?
Both models are legal. Neither is universally better. What matters is that the provider is transparent about which one they use and why.
Video consultations are higher-touch. The clinician sees you, can ask follow-up questions in real time, and can respond to nuance in what you say. They're slower and more expensive to run at scale.
Asynchronous (async) consultations are message-based. You submit intake, the clinician reviews on their own schedule, and you exchange messages if there are questions. They're faster and cheaper, and they're clinically appropriate for a wide range of care.
The question isn't which one you're getting. It's whether the provider is honest about it. A platform advertising "personalised consultations" that turns out to be a five-minute form followed by an automatic approval is misleading. A platform saying clearly "we use asynchronous review by a licensed clinician who typically responds within twenty-four hours" is being straight.
Question 4: What happens if the provider decides I'm not eligible?
This is the single most useful diagnostic question you can ask, and almost no one does.
A provider whose intake process can return "you're not a candidate for this" is a provider whose intake process is doing real clinical work. A provider whose intake process returns "approved" for every intake that pays the consultation fee is a provider whose intake process is a payment funnel.
Legitimate telehealth clinicians decline patients regularly — for interacting medications, unmanaged conditions, contraindicated goals, or simply because the clinical picture warrants an in-person evaluation first. Ineligibility is not a bug. It's a signal of clinical rigour.
Ask: what percentage of intakes are declined, and what happens to the fee if I'm one of them? A serious provider has an answer. An unserious one gets defensive.
Question 5: How are the costs actually structured?
Cash-pay telehealth pricing falls into three components: the consultation or subscription fee, the medication itself, and any dispensing or shipping fees. Reputable providers itemise all three. Less reputable providers bundle them into a single monthly price designed to obscure margin.
Questions worth asking before signing up:
Is the price I see on the landing page the price I'll actually pay, or are there additional fees at checkout?
Is the medication price fixed, or does it scale with dose or protocol complexity?
What am I charged if I pause, cancel, or change protocols?
Are there commitments — annual plans, minimum months — that lock in the price?
Transparent pricing is not just an ethics signal. It's an operational signal. A provider that hasn't done the work to itemise their own economics is unlikely to have done the work on the parts of the operation you can't see.
Question 6: Who owns my medical records, and can I take them with me?
If you decide to leave, what do you keep?
Ideally: a full record of your intake, clinical notes, prescriptions, protocol history, and any lab work — portable, in a format you can hand to another clinician. This is the standard patients receive from any traditional practice. It should be the standard from telehealth.
In practice, some telehealth platforms treat your record as their asset. Leaving means starting over: new intake, new history, no continuity. That's not a legal issue — telehealth providers can operate this way — but it's a philosophical one. The provider is telling you that your data works for them, not for you.
Ask before you sign up: if I want to leave in twelve months, what records can I take with me, in what format? A serious provider gives you a straight answer.
Question 7: How does the provider adjust my protocol over time — reactive or systematic?
Most telehealth is reactive. You start on a protocol. If you have a problem, you message the platform, and someone responds. If you don't message anyone, nothing changes. Your protocol at month twelve is your protocol from month one.
Systematic personalisation is different. The provider has a framework for reviewing your protocol at defined intervals — typically at the end of each cycle — and adjusting based on what worked, what didn't, and what you reported. The adjustment isn't triggered by a problem. It's built into the model.
The difference matters most in longer-term care. A reactive provider is fine for a single course of treatment. A systematic provider is what you want for anything ongoing.
Ask: how often is my protocol reviewed, who reviews it, and what data informs the review? If the answer is "reach out if you have questions," you've learned something.
Test
This article is general education, not medical advice, and is not a recommendation for any specific medication. Consult with a licensed healthcare provider to determine what treatment is appropriate for you.
Clinically reviewed by
Amelia Baweja
